David Northcutt
Foot & Ankle Surgery · Bloomington, INNPI 1922235340
Payments from drug & device makers
Across 29 payments — averaging $85.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pylant Medical$1K
- Treace Medical Concepts, Inc.$786
- Melinta Therapeutics, LLC$121
- Stryker$72
- Smith+Nephew$54
- Globus Medical$33
- plus $285 from 14 others
What the payments were for
- Travel & lodging$74430%
- Food & beverage$60725%
- Education$1,11545%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pylant Medical | 1 | $1,115 |
| Treace Medical Concepts, Inc. | 4 | $786 |
| Melinta Therapeutics, LLC | 1 | $121 |
| Stryker | 3 | $72 |
| Smith+Nephew | 3 | $54 |
| Globus Medical | 1 | $33 |
| Johnson & Johnson | 1 | $30 |
| Kerecis Limited | 2 | $27 |
| MF MED | 1 | $25 |
| Orthofix Medical, Inc. | 2 | $23 |
| Abbott | 1 | $22 |
| DJO, LLC | 1 | $21 |
| Averitas Pharma Inc. | 1 | $21 |
| Boston Scientific | 1 | $19 |
| Paratek Pharmaceuticals, Inc. | 1 | $18 |
| Organogenesis Inc. | 1 | $18 |
| Integra Lifesciences Corporation | 1 | $18 |
| Normatec Industries, LP | 1 | $16 |
| Vertex | 1 | $16 |
| Tactile Systems Technology Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lapiplasty System$744
- Baxdela$121
How this compares
$2,466 in reported general payments places this provider in the 35th percentile of 212 foot & ankle surgery providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciclopirox | 13 | $337 |
| Cephalexin | 31 | $180 |
| CiclopiroxCiclopirox Olamine | 11 | $166 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 25 | $141 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 17 | $127 |
| Mupirocin | 19 | $126 |
| Silver Sulfadiazine | 19 | $103 |
| Ciprofloxacin Hcl | 15 | $91 |
| Doxycycline Hyclate | 13 | $76 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 16 | $46 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Bloomington
- Steven HerbstMuncie$1.6M
- Douglas BlacklidgeKokomo$689K
- Patrick DeheerIndianapolis$493K
- Scott NevilleMooresville$353K
- Travis MontgomeryWestfield$345K
- Robert Clemency IiiSchererville$215K
- William AdamsGreenfield$178K
- Christopher WintersCarmel$158K
- Steven DouthettFort Wayne$153K
- Brian ElliottShelbyville$142K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.